Breast Neoplasms: all 12,820 studies
Page 105 of 129. Open to participants first (2,923), then studies with results posted, then the rest; newest registration first within each.
- S1008: Exercise, Diet, & Counseling in Improving Weight Loss in Overweight Female Breast or Colorectal Cancer SurvivorsCompletedNCT01453452Not applicable
- Resource-sparing Post-mastectomy Radiotherapy in Breast CancerStatus unknownNCT01452672Phase 3
- A Randomized Controlled Trial of Routine Shave Margins Versus Standard Partial Mastectomy in Breast Cancer PatientsCompletedNCT01452399Not applicable
- Lipo-dox and Cyclophosphamide /5-Fluorouracil in Patients With Metastatic Breast CancerStatus unknownNCT01451580Phase 2
- Peer Navigator Education in Improving Survivorship Care in African American Breast Cancer SurvivorsActive, not recruitingNCT01450020Not applicable
- Decision Support for Women With Breast CancerTerminatedNCT01447771Not applicable
- Treatment Decision Impact of OncotypeDX™ in HR+, N- Breast Cancer PatientsCompletedNCT01446185Not applicable
- AZD2281 Plus Carboplatin to Treat Breast and Ovarian CancerCompletedNCT01445418Phase 1
- 111 Indium CHX-A DTPA Trastuzumab (Indium-Herceptin) for Imaging Breast CancerTerminatedNCT01445054Early Phase 1
- Rural Women Connecting for Better HealthCompletedNCT01441011Not applicable
- Study of the Response to a Neoadjuvant Chemotherapy Based on the Antitumor Immune Response in Localized Breast CancerStatus unknownNCT01440413Not applicable
- Study of Cipterbin®, Used Alone or With Vinorelbine in Patients With HER2/Neu-overexpressed Metastatic Breast CancerCompletedNCT01439191Phase 2
- Gadofosveset for Axillary Staging in Breast Cancer PatientsCompletedNCT01437865Not applicable
- Study of GDC-0941 or GDC-0980 With Fulvestrant Versus Fulvestrant in Advanced or Metastatic Breast Cancer in Participants Resistant to Aromatase Inhibitor TherapyCompletedNCT01437566Phase 2
- Early Detection of Cardiac Toxicity of Trastuzumab (Herceptin ®) in Patients Treated for Breast Carcinoma: Value of Magnetic Resonance ImagingTerminatedNCT01436604Phase 2
- Comparison of Diagnostic Performance of an Algorithm and a High Definition Classical Iterative Algorithm Positron Emission Tomography (PET) to 18Fluoro-deoxy-glucose (18FDG) in the Evaluation of Axillary Lymph Node Invasion of Breast TumorsTerminatedNCT01436591
- Breast Cancer and Exercise Trial in AlbertaCompletedNCT01435005Not applicable
- Triple Negative Breast Cancer: Study of Molecular and Genetic FactorsStatus unknownNCT01434420Not applicable
- Entinostat, Lapatinib Ditosylate and Trastuzumab in Treating Patients With Locally Recurrent or Distant Relapsed Metastatic Breast Cancer Previously Treated With Trastuzumab OnlyCompletedNCT01434303Phase 1
- Prevention of Cardiac Dysfunction During Adjuvant Breast Cancer TherapyCompletedNCT01434134Phase 2
- Characteristics of Disseminated Her2+ Breast Cancer Patients Treated With Trastuzumab That Have Reached Complete, Partial Remission or Stabilization of Disease During More Than 3 YearsCompletedNCT01433926
- Epirubicin and Paclitaxel, Alone or Together With Capecitabine as First Line Treatment in Metastatic Breast CancerCompletedNCT01433614Phase 3
- Efficacy and Safety of DLBS1425 as Neoadjuvant in Stage II or III Breast Cancer PatientsCompletedNCT01433562Phase 2/3
- Primary Chemotherapy With Anthracycline Followed by Nab-paclitaxel and TrastuzumabCompletedNCT01432223Phase 2
- FDG-PET/CT for Simulation and Radiation Treatment Planning of Early Breast CancerStatus unknownNCT01432002
- Systemic Dickkopf-related Protein 1 (DKK1)During Estrogen Level Changes in Post-menopausal Breast Cancer Patients Treated With Aromatase InhibitorsCompletedNCT01431872
- Trial With Autologous Dendritic Cell Vaccination in Patients With Stage II-III HER2 Negative Breast CancerCompletedNCT01431196Phase 2
- Study of Aspirin and Exemestane as Adjuvant Treatment in Breast CancerStatus unknownNCT01431053Phase 2
- Correlation Between MRS (Magnetic Resonance Spectroscopy) and Tumor Response to Radiation Therapy in Breast CancerCompletedNCT01428739Not applicable
- Efficacy and Safety Study of Trastuzumab and Paclitaxel Based Regimens to Treat HER2-positive Breast CancerStatus unknownNCT01428414Phase 2
- The Use of Botulinum Toxin A in Two-Stage Tissue Expander/ Implant Breast ReconstructionStatus unknownNCT01427400Phase 4
- Non-Invasive Imaging for Cording in Breast Cancer PatientsCompletedNCT01427166Not applicable
- Addition of Carboplatin to Neoadjuvant Therapy for Triple-negative and HER2-positive Early Breast CancerCompletedNCT01426880Phase 2/3
- Changes in Breast Cancer Biomarkers Using Synergistic Prostaglandin InhibitorsCompletedNCT01425476Phase 1/2
- Collection of Efficacy and Safety Data of Chinese Patients Who Have Received Faslodex 250mg TreatmentTerminatedNCT01425294
- CRRS-4 Pivotal Somo•v™ ABUS ROC Reader Observer StudyCompletedNCT01424956
- Cancer Stem Cell Biomarkers as a Predictor of Response to Trastuzumab in Samples From Patients With Breast Cancer Previously Treated in the NSABP-B-31 TrialStatus unknownNCT01424865
- A Prospective Cohort Study to Evaluate the Oncotype DX® Test in Early Stage Breast CancerCompletedNCT01423890Not applicable
- Weekly Paclitaxel and Trastuzumab in Metastatic Breast CancerCompletedNCT01423695Phase 2
- Combination of Weekly Paclitaxel With Neratinib and Trastuzumab in Women With Metastatic HER2-positive Breast CancerCompletedNCT01423123Phase 1
- Facilitating Positive Adaptation to Breast CancerCompletedNCT01422551Phase 2
- Identification of Genes That Predict Local Recurrence in Samples From Patients With Breast Cancer Treated on NSABP-B-28Status unknownNCT01420185
- Promoting a Healthier Lifestyle Among Breast Cancer SurvivorsCompletedNCT01419613Not applicable
- Nab-paclitaxel in Metastatic Breast Cancer Patients Failing Solvent Based Taxane (Tiffany)TerminatedNCT01416558Phase 2
- AX Versus AC as Adjuvant Treatment for Node-Negative Breast CancerStatus unknownNCT01415336Phase 2/3
- High Throughput Technologies to Drive Breast Cancer Patients to Specific Phase I/II Trials of Targeted AgentsCompletedNCT01414933
- Trastuzumab Administered Concurrently or Sequentially to Anthracycline-containing Adjuvant Regimen for Breast CancerCompletedNCT01413828Phase 2/3
- Randomized Study of Hypofractionated and Conventional Fractionation Radiotherapy After Breast Conservative SurgeryCompletedNCT01413269Phase 3
- Epigenetics and Psychoneurologic Symptoms in Women With Breast CancerCompletedNCT01411943
- Bootcamp During Neoadjuvant Chemotherapy for Breast CancerCompletedNCT01411787Not applicable
- TORI 104 Pre-Surgical DasatinibWithdrawnNCT01410708Phase 2
- 3.0 Tesla Magnetic Resonance Imaging for Breast Cancer Detection in High Risk WomenWithdrawnNCT01409226Not applicable
- Genetic Susceptibility to Radiation-Induced Skin Reactions in Racial/Ethnic Groups of Patients With Breast CancerCompletedNCT01407770
- Wound Infiltration and Breast Cancer SurgeryCompletedNCT01404377Phase 4
- Comparison of the Cosmetic Outcome of Hypofractionated Versus Normofractionated IMRT in Treatment of Breast CancerCompletedNCT01403779Phase 3
- Effects of Controlled Ovarian Hyperstimulation (COH) With Letrozole and GonadotropinCompletedNCT01403688
- Comparative Evaluation of Osteopathy Treatment Efficacy in Pain Support After Breast Surgery in OncologyTerminatedNCT01403168Not applicable
- Study of Arimidex and Radiotherapy SequencingStatus unknownNCT01402193Phase 3
- Experience of the Patient Treated With Trastuzumab (Herceptin ®) as Adjuvant for Breast CancerCompletedNCT01400438Not applicable
- Cosmetic Evaluation of Lumpectomy Versus Oncolytic Mammoplasty With Bilateral Breast Reduction for Early Stage Breast CancerStatus unknownNCT01400399
- Factors Influencing Decision-Making About the Use of Chemoprevention in Women at Increased Risk for Breast CancerCompletedNCT01399359
- Fulvestrant in Postmenopausal Patients With Metastatic Breast CancerCompletedNCT01399086
- PET in Breast Cancer Receiving Neoadjuvant ChemotherapyCompletedNCT01396655Phase 2
- A Novel Prosocial Online Support Group for Distressed Breast Cancer SurvivorsCompletedNCT01396174Not applicable
- ICG Fluorescence Technique for the Detection of Sentinel Lymph NodesStatus unknownNCT01395706Phase 2
- Study of Chemotherapy With Adoptive Cellular Therapy With DC-CIK Cells in Triple Negative Breast Cancer PatientsCompletedNCT01395056
- Whole Breast Irradiation With Intensity Modulated Radiotherapy and Simultaneously Integrated Boost for Early Stage Breast Cancer PatientsStatus unknownNCT01394575Phase 2
- Diffuse Optical Tomography (DOT) for Monitoring Response to Neoadjuvant (Preoperative) Chemotherapy in Breast CancerTerminatedNCT01394315
- Systemic Therapy With or Without Upfront Surgery in Metastatic Breast CancerTerminatedNCT01392586Phase 3
- Prediction of Pain After Breast Cancer Surgery With EEGTerminatedNCT01392248
- Psychosocial Adjustment of Patients and Their Partners Following Breast Cancer DiagnosisCompletedNCT01392066
- The Impact of Preoperative Breast MRI in Patients With Breast Cancer Selected for Breast Conserving SurgeryCompletedNCT01391806
- Diindolylmethane in Treating Patients With Breast CancerCompletedNCT01391689Not applicable
- Intra-hepatic Chemotherapy in Patient With Non-resectable Liver Metastases From Breast CancerCompletedNCT01387373Phase 2
- Understanding Decision Making Processes for Undergoing Genetic Testing Among Women With Newly Diagnosed Breast CancerCompletedNCT01386411
- Exercise Training in Postmenopausal Patients With Breast CancerCompletedNCT01384838Not applicable
- Investigating the Impact of Tamoxifen Therapy on Ovarian AgingCompletedNCT01384526
- Safety Study of ²¹²Pb-TCMC-Trastuzumab Radio ImmunotherapyCompletedNCT01384253Phase 1
- Assessment of Cognitive Function in Breast Cancer and Lymphoma Patients Receiving ChemotherapyActive, not recruitingNCT01382082
- The Jewels in Our Genes Study - an African American Family Study of Breast CancerCompletedNCT01380925
- Can Methylprednisoloneacetate Prevent Seroma After Mastectomy for Primary Breast CancerStatus unknownNCT01380912
- Capecitabine and Pseudomonas Aeruginosa Combination in Metastatic Breast Cancer (MBC)CompletedNCT01380808Phase 2
- Test Uniformity of Transdermal Drug Delivery to Breast Using Diclofenac EpolamineCompletedNCT01380353Early Phase 1
- The Trial Comparing Dose-dense AC-T With PC as Adjuvant Therapy for TNBCStatus unknownNCT01378533Phase 3
- Evaluation of Degree of Conversion of HER2 Receptor Between Primary Breast Cancer and MetastasisCompletedNCT01377363
- Molecular Imaging of Fulvestrant Effects on Availability of ER Binding SitesCompletedNCT01377324Phase 2
- Exercise Controls Tumor Cell Growth Through AMPK ActivationStatus unknownNCT01376583
- Allogenic Haematopoietic Cell Transplantation for Patients With Refractory "Triple Negative" Breast CancerTerminatedNCT01375023Phase 2
- Intrathecal Trastuzumab Administration in Metastatic Breast Cancer Patients Developing Carcinomatous MeningitisCompletedNCT01373710Phase 1/2
- Evaluating AlloMax in Immediate Expander-Based Breast Reconstruction StudyCompletedNCT01372917
- A Novel Optical Spectral Imaging System for Imaging Breast Tumor MarginsCompletedNCT01372631Not applicable
- Carboplatin and Eribulin Mesylate in Triple Negative Breast Cancer PatientsStatus unknownNCT01372579Phase 2
- HumanaH - Hu3s193 in the Treatment of Advanced Breast Cancer After Hormonal TherapyTerminatedNCT01370239Phase 2
- Clinical Evaluation of OSNA Breast Cancer System to Extensive Frozen Section HistopathologyCompletedNCT01368744
- Hand in Hand. Psychological Support and Counseling to Breast Cancer Patients and Their PartnersCompletedNCT01368380Not applicable
- Study Evaluating Impact of IL-7 on CD4 Lymphopenia, Risks of Severe Haematological Toxicity and Tumor Progression in Metastatic Breast Cancer PatientsCompletedNCT01368107Phase 2
- Comparative Study of Neoadjuvant Chemotherapy With and Without Zometa for Management of Locally Advanced Breast CancersCompletedNCT01367288Phase 2
- A Phase II Study of Neoadjuvant Trastuzumab+Docetaxel+NPLD+/-Bevacizumab in Her2-pos. Early Breast CancerCompletedNCT01367028Phase 2
- Integrative Oncology Outcomes Study in Breast CancerCompletedNCT01366248
- Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney DysfunctionActive, not recruitingNCT01366144Phase 1